Cargando…
First glycopeptide-resistant Enterococcus faecium isolate from blood culture in Ankara, Turkey.
Autores principales: | Basustaoglu, A, Aydogan, H, Beyan, C, Yalcin, A, Unal, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631688/ https://www.ncbi.nlm.nih.gov/pubmed/11266313 |
Ejemplares similares
-
First Characterization of a Cluster of VanA-Type Glycopeptide-Resistant Enterococcus faecium, Colombia
por: Panesso, Diana, et al.
Publicado: (2002) -
Algorithm for empirical glycopeptide treatment in patients with hematologic malignancies and enterococcus faecium blood stream infection
por: Zhou, X, et al.
Publicado: (2011) -
Acquisition of Daptomycin Resistance by Enterococcus faecium Confers Collateral Sensitivity to Glycopeptides
por: Zeng, Weiliang, et al.
Publicado: (2022) -
Daptomycin versus Glycopeptides for the Treatment of Enterococcus faecium Bacteraemia: A Cohort Study
por: Echeverría-Esnal, Daniel, et al.
Publicado: (2021) -
Algorithm for pre-emptive glycopeptide treatment in patients with haematologic malignancies and an Enterococcus faecium bloodstream infection
por: Zhou, Xuewei, et al.
Publicado: (2013)